StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences cash

Cash and short-term investments held at the end of each period.

Pulse Biosciences's cash was $101.62M at Jun 30, 2026. For fiscal 2025 it was $80.74M, down 31.6% from the year before. Over ten years it grew 36.5% a year on average. The highest annual figure on record is $118.04M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.74M-31.6%
FY2024Dec 31, 2024$118.04M+166.1%
FY2023Dec 31, 2023$44.37M-27.4%
FY2022Dec 31, 2022$61.14M+113.8%
FY2021Dec 31, 2021$28.60M+39.7%
FY2020Dec 31, 2020$20.48M+196.8%
FY2019Dec 31, 2019$6.90M-88.4%
FY2018Dec 31, 2018$59.58M+56.5%
FY2017Dec 31, 2017$38.07M+132.2%
FY2016Dec 31, 2016$16.40M+354.7%
FY2015Dec 31, 2015$3.61M-48.6%
FY2014Dec 31, 2014$7.01M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$101.62M-4.4%
Q1 FY2026Mar 31, 2026$68.32M-42.7%
Q4 FY2025Dec 31, 2025$80.74M-31.6%
Q3 FY2025Sep 30, 2025$95.21M+20.5%
Q2 FY2025Jun 30, 2025$106.35M+306.0%
Q1 FY2025Mar 31, 2025$119.28M+241.9%
Q4 FY2024Dec 31, 2024$118.04M+166.1%
Q3 FY2024Sep 30, 2024$79.03M+56.9%
Q2 FY2024Jun 30, 2024$26.20M-55.4%
Q1 FY2024Mar 31, 2024$34.89M-35.5%
Q4 FY2023Dec 31, 2023$44.37M-27.4%
Q3 FY2023Sep 30, 2023$50.39M-27.1%
Q2 FY2023Jun 30, 2023$58.75M+296.9%
Q1 FY2023Mar 31, 2023$54.10M+326.0%
Q4 FY2022Dec 31, 2022$61.14M+113.8%
Q3 FY2022Sep 30, 2022$69.16M+64.7%
Q2 FY2022Jun 30, 2022$14.80M-68.8%
Q1 FY2022Mar 31, 2022$12.70M-78.8%
Q4 FY2021Dec 31, 2021$28.60M+39.7%
Q3 FY2021Sep 30, 2021$42.00M+41.9%
Q2 FY2021Jun 30, 2021$47.43M+25.6%
Q1 FY2021Mar 31, 2021$59.88M+276.6%
Q4 FY2020Dec 31, 2020$20.48M+196.8%
Q3 FY2020Sep 30, 2020$29.60M-14.2%
Q2 FY2020Jun 30, 2020$37.77M-11.4%
Q1 FY2020Mar 31, 2020$15.90M-69.9%
Q4 FY2019Dec 31, 2019$6.90M-88.4%
Q3 FY2019Sep 30, 2019$34.50M+64.1%
Q2 FY2019Jun 30, 2019$42.64M+55.1%
Q1 FY2019Mar 31, 2019$52.80M+58.2%
Q4 FY2018Dec 31, 2018$59.58M+56.5%
Q3 FY2018Sep 30, 2018$21.02M-50.0%
Q2 FY2018Jun 30, 2018$27.50M+78.6%
Q1 FY2018Mar 31, 2018$33.38M+77.0%
Q4 FY2017Dec 31, 2017$38.07M+132.2%
Q3 FY2017Sep 30, 2017$42.04M+124.7%
Q2 FY2017Jun 30, 2017$15.40M–
Q1 FY2017Mar 31, 2017$18.86M–
Q4 FY2016Dec 31, 2016$16.40M–
Q3 FY2016Sep 30, 2016$18.71M–

More Pulse Biosciences figures

See a number that looks wrong?